GHENT, BELGIUM– – Ablynx [Euronext Brussels: ABLX] todayannouncedthat Boehringer Ingelheim has submitted a Clinical Trials Application tothe European regulatory authorities to start a Phase I clinical …
Continued here:
Nanobody for ... continue reading
A research team today announced the launch of a European large-scale clinical trial of Nilvadipine, an Alzheimer’s disease drug developed at the Roskamp Institute in Sarasota.
View post:
Key Clinical Trial of Alzheimer’s Disease Drug Begins in Europe
An international research consortium led by Trinity College Dublin today announced the selection for funding of a large-scale European clinical trial of Nilvadipine, an Alzheimer’s disease drug developed at the Roskamp Institute in Sarasota.
The rest is here:
... continue reading
US and European researchers have identified two new genes that may play a role in the development of Alzheimer’s disease and could help unravel new treatments, a study published Tuesday said.
See the original post:
Research finds new genes ... continue reading
The Austrian biotechnology firm Affiris announced Friday that a new vaccine against Alzheimer’s will soon be tested in six European countries.
Read the rest here:
Alzheimers Vaccine Closer To Reality